Generic battle for Ultracet

Published: 2008-09-02 06:43:00

Updated: 2008-09-02 06:43:00

With many global makers' blockbuster products coming off patent, the race for the generic drug market is set to be in full force in the second half of this year.

Recently, the drug at the center of attention is the best-selling Ultracet (tramadol/acetaminophen), an analgesic for management of ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK